Incidence, mortality, and risk factors associated with carbapenem‐resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation

Outcomes after Liver Transplantation in Korea: Incidence and Risk Factors from Korean Transplantation Registry

(2021) Jong Man Kim et al.   Clinical and Molecular Hepatology

Risk factor forlung infection in recipients after liver transplantation:a meta‐analysis

(2020) Jiaxue Zhang et al.   ARTIFICIAL ORGANS

Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients

(2018) Y.J. Kim et al.   TRANSPLANTATION PROCEEDINGS

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients

(2017) James M. Neuberger et al.   TRANSPLANTATION

The evolving threat of carbapenem-resistant infections after liver transplantation: The case ofAcinetobacter baumannii

(2016) Marcus R. Pereira et al.   LIVER TRANSPLANTATION

Carbapenem-resistantAcinetobacter baumanniiacquired before liver transplantation: Impact on recipient outcomes

(2016) Maristela Pinheiro Freire et al.   LIVER TRANSPLANTATION

Risk factors and outcomes of carbapenem-resistantKlebsiella pneumoniaeinfections in liver transplant recipients

(2015) Marcus R. Pereira et al.   LIVER TRANSPLANTATION

The impact of pretransplant hepatic encephalopathy on survival following liver transplantation

(2015) Robert J. Wong et al.   LIVER TRANSPLANTATION

Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality

(2014) Q.F. Ye et al.   Transplant Infectious Disease

Bacterial infection after liver transplantation

(2014) Sang Il Kim   WORLD JOURNAL OF GASTROENTEROLOGY

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

(2013) E. Tacconelli et al.   CLINICAL MICROBIOLOGY AND INFECTION

Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: An analysis of the epidemiology, risk factors, and outcomes

(2013) Maristela Pinheiro Freire et al.   LIVER TRANSPLANTATION

Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation

(2013) Robert W. Krell et al.   LIVER TRANSPLANTATION

Risk Factors and Outcomes of Bacteremia Caused by Drug-Resistant ESKAPE Pathogens in Solid-Organ Transplant Recipients

(2013) Marta Bodro et al.   TRANSPLANTATION

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-SusceptibleAcinetobacter baumannii

(2013) Hee Kyoung Choi et al.   YONSEI MEDICAL JOURNAL

Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)

(2012) René Adam et al.   JOURNAL OF HEPATOLOGY

Multidrug-resistant gram-negative bacterial infections after liver transplantation – Spectrum and risk factors

(2011) Lin Zhong et al.   JOURNAL OF INFECTION

The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom

(2011) William Gelson et al.   TRANSPLANTATION

Multidrug-ResistantAcinetobacterspp.: Increasingly Problematic Nosocomial Pathogens

(2011) Kyungwon Lee et al.   YONSEI MEDICAL JOURNAL

Treatment ofAcinetobacterInfections

(2010) Joel Fishbain et al.   CLINICAL INFECTIOUS DISEASES

Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy

(2009) M.F. Dalben et al.   JOURNAL OF HOSPITAL INFECTION

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES